Natera

This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (June 2021)

Natera, Inc.

Formerly	Gene Security Network, Inc. (2004–2012)
Company type	Public
Traded as	Nasdaq: NTRA Russell 1000 component
Industry	Genetic testing
Founded	2004; 20 years ago (2004)
Founders	Matthew Rabinowitz Jonathan Sheena
Headquarters	Austin, Texas, U.S.
Key people	Steve Chapman (CEO) Rishi Kacker (CTO) Matthew Rabinowitz (executive chairman)
Revenue	US$797 million (2022)
Operating income	US$−541 million (2022)
Net income	US$−548 million (2022)
Total assets	US$1.39 billion (2022)
Total equity	US$706 million (2022)
Number of employees	3,018 (2022)
Website	natera.com
Footnotes / references [1]

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.